{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:46:27Z","timestamp":1758638787253},"reference-count":32,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T00:00:00Z","timestamp":1219881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>A combination of clarithromycin, low dose of thalidomide and low dose dexamethasone was used in a phase II study to treat patients with relapsed and refractory myeloma. Thirty patients received clarithromycin 250\u2003mg twice daily and thalidomide 50\u2003mg at night on an ongoing basis with 4\u2010d pulses of 10\u2003mg dexamethasone given monthly. Eight patients had permitted escalation of thalidomide dosage up to 200\u2003mg daily. The combination was well tolerated and could be given to elderly, infirm and severely cytopenic patients. Response rates were high, with 89% achieving at least 50% reduction in paraprotein and a 96% overall response rate. Although clarithromycin has only minimal anti\u2010myeloma properties when used as a single agent, its combination with thalidomide and dexamethasone appears very effective, allowing these to be used in lower and more tolerable doses with good clinical effects.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2008.07360.x","type":"journal-article","created":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T13:48:21Z","timestamp":1219931301000},"page":"349-354","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clarithromycin with low dose dexamethasone and thalidomide is effective therapy in relapsed\/refractory myeloma"],"prefix":"10.1111","volume":"143","author":[{"given":"T. C. M.","family":"Morris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. J.","family":"Kettle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. C. G.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. R.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,14]]},"reference":[{"key":"e_1_2_5_2_1","first-page":"383","article-title":"Thalidomide\u2010based treatment for HIV\u2010associated multiple myeloma: case report","volume":"13","author":"Aboulafia D.","year":"2003","journal-title":"AIDS Reader"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70068-4"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607113350204"},{"key":"e_1_2_5_5_1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","article-title":"Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine","volume":"47","author":"Bradwell A.R.","year":"2001","journal-title":"Clinical Chemistry"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190600879813"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022340"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000006303"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00976.x"},{"key":"e_1_2_5_10_1","article-title":"Clarithromycin (Biaxin) as primary treatment for myeloma","volume":"90","author":"Durie B.G.M.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05914.x"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200259"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04473.x"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05521.x"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1996.46752.x"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06919.x"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401332"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.11.2643"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.6.1366"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1385\/MO:18:1:79"},{"key":"e_1_2_5_21_1","first-page":"658","article-title":"Inefficacy of clarithromycin in advanced multiple myeloma: a definitive report","volume":"87","author":"Musto P.","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_5_22_1","first-page":"140","article-title":"Clarithromycin induces autophagy in myeloma cells","volume":"92","author":"Nakamura M.","year":"2007","journal-title":"Haematologica"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701647887"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-090258"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68338-4"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.0221"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043445"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015909"},{"key":"e_1_2_5_29_1","first-page":"862","article-title":"Combination chemotherapy with cyclophosphamide, thalidomide and dexamethasone for patients with refractory, newly diagnosed or relapsed myeloma","volume":"91","author":"Sidra G.","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199911183412102"},{"key":"e_1_2_5_31_1","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood.V93.12.4441","article-title":"Lack of response to short\u2010term use of clarithromycin (BIAXIN) in multiple myeloma","volume":"93","author":"Stewart A.K.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004330050068"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh026"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2008.07360.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2008.07360.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T10:54:40Z","timestamp":1697453680000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2008.07360.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,14]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1111\/j.1365-2141.2008.07360.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07360.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,14]]},"assertion":[{"value":"2008-10-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}